MRSA

>

Latest News

Similar Efficacy of Ceftaroline and Vancomycin in Treating Complicated Skin and Soft Tissue Infections
Similar Efficacy of Ceftaroline and Vancomycin in Treating Complicated Skin and Soft Tissue Infections

May 11th 2024

A comparative study presented MAD-ID, The Antimicrobial Stewardship Meeting examining the effectiveness of ceftaroline and vancomycin in addressing this challenge.

Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes
Exebacase Combined With Antibiotics Fails to Improve MRSA Bacteremia Outcomes

February 8th 2024

Evaluating the Efficacy of Daptomycin and Ceftaroline for the Treatment of MRSAB
Evaluating the Efficacy of Daptomycin and Ceftaroline for the Treatment of MRSAB

May 20th 2021

Eravacycline Realizes Successful Clinical Endpoint in OPAT Facilities
Eravacycline Realizes Successful Clinical Endpoint in OPAT Facilities

June 11th 2020

CAMERA2: Standard MRSA Treatment Does Not Outperform Combination Therapy
CAMERA2: Standard MRSA Treatment Does Not Outperform Combination Therapy

February 19th 2020

Video Series
Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.